Earnings Recaps & Summaries

AI-powered summaries of the latest quarterly earnings reports. Key takeaways distilled from earnings calls so you can stay informed in seconds.

See the upcoming earnings calendar →

Latest Recaps

November 12, 2026

Archer Aviation Inc. Class A Common Stock

ACHR Q3 2026

Shares fell 2.1% after earnings, a roughly flat reaction. Archer highlighted progress toward city operations and FAA certification, but the transcript also shows type certification remains in its final implementation phase and piloted transition is still in progress.

Amprius Technologies, Inc.

AMPX Q3 2026

Amprius shares fell 6.8% after earnings, despite higher revenue and a raised full-year target; the likely concern is that the increase was modest relative to the reported growth, while much of the capacity expansion remains prospective, with the new U.S. line not expected to be complete until early 2028. The transcript does not provide enough information to identify a specific financial miss.

Barrick Mining Corporation

B Q3 2026

Shares fell 2.1% after earnings, a roughly flat reaction. The quarter included higher gold production and solid cash generation, while weather disruptions persisted into early Q4 and copper costs are expected near the top of the full-year range.

B&G Foods, Inc.

BGS Q3 2026

B&G Foods’ shares jumped 38.0% after earnings, as the company reported 5% third-quarter base-business sales growth and raised its full-year sales and adjusted EBITDA guidance. The growth was primarily volume-driven, though year-to-date base-business sales growth remained more modest at 1.8%.

Bakkt Holdings Inc. Class A Common Stock

BKKT Q3 2026

Bakkt shares fell 10.3% after the company reported lower third-quarter transaction volume and reiterated a full-year target that requires a steep fourth-quarter ramp. The key risk is execution: the expected institutional and cross-border flows were still in integration, and management said launch timing and subsequent client activity are critical.

Bitdeer Technologies Group Class A Ordinary Shares

BTDR Q3 2026

Bitdeer’s shares rose 6.4% after earnings, with investors responding to sharply higher revenue and expanding contracted AI demand. The upside was tempered by AI cloud’s modest 15% gross margin and the fact that Bitcoin mining still provides most near-term revenue.

Capricor Therapeutics, Inc.

CAPR Q3 2026

Capricorn Therapeutics shares rose 26.5% after the earnings call, as investors responded to the company’s account of positive HOPE-3 efficacy data and its view that the FDA review is nearing completion. The BLA remains under review, with the agency’s target action date extended to November 22.

Constellation Energy Corporation

CEG Q3 2026

Constellation beat with third-quarter adjusted operating earnings of $5.06 per share and raised full-year guidance to $12.50–$12.80 per share; shares rose 10.5% after earnings. The company also announced long-term nuclear agreements that extend earnings visibility and support planned new capacity.

Coherus BioSciences, Inc.

CHRS Q3 2026

Coherus shares fell 21.6% after earnings, as investors appear to have focused on the company’s need to sharply reduce costs and its reliance on growing LOQTORZI revenue to cover core cash burn. Management plans a 30% headcount reduction and narrowed tagmokitug development to esophageal cancer, but the transcript does not provide evidence that LOQTORZI has yet reached the revenue level needed to support the business.

Delcath Systems, Inc.

DCTH Q3 2026

Delcath’s shares rose 35.8% after a record $35.1 million in third-quarter revenue, up 71% year over year, alongside positive operating cash flow. HEPZATO volume growth and improving profitability were the clearest positives, while slower-than-expected breast cancer trial enrollment remains a development risk.

Mind Medicine (MindMed) Inc.

DFTX Q3 2026

Definium shares fell 2.1% after the earnings call, a roughly flat reaction. The update included positive Phase 3 findings and regulatory progress, but the next major MDD readout remains ahead: ASCEND top-line data are expected in 2027.

Draganfly Inc. Common Shares

DPRO Q3 2026

Draganfly shares fell 10.4% after earnings, as investors focused on slightly lower revenue and sharply squeezed gross margin: Q3 revenue declined year over year, while gross margin was 6.3%. Management highlighted defense opportunities and certifications, but the transcript provides no quantified outlook to offset the weak quarter’s financial signals.

Viant Technology Inc.

DSP Q3 2026

Viant shares fell 12.2% after earnings, despite Q3 results above the company’s guidance ranges. The likely disappointment is the cautious outlook: Q4 contribution ex-TAC guidance implies a sharp sequential slowdown from Q3, with the midpoint indicating roughly 8% quarter-over-quarter growth versus 27% year-over-year growth in Q3.

Elmet Group Co.

ELMT Q3 2026

Elmet shares fell 11.9% after earnings. The transcript reports sharp revenue and adjusted EBITDA growth, but most revenue growth came from higher tungsten and molybdenum prices rather than demand, while the provided remarks do not include a forward outlook to reassure investors about the growth trajectory.

Embraer S.A.

EMBJ Q3 2026

Embraer’s shares rose 7.0% after the company reported record third-quarter revenue and raised its 2026 revenue and free-cash-flow guidance. The unchanged adjusted EBIT margin outlook and lower year-over-year net income temper the upbeat headline.

Evolution Petroleum Corporation

EPM Q1 2027

Evolution Petroleum’s shares fell 3.6% after earnings, with the transcript pointing to a quarterly net loss and continued focus on paying down debt as likely concerns. Management highlighted improving royalty production and acquisition contributions, but provided no clear near-term outlook beyond expected production additions in the second quarter.

eToro Group Ltd.

ETOR Q3 2026

eToro’s shares fell 1.4% after earnings, a roughly flat reaction. The quarter showed record equity assets, but lower market volatility weighed on trading activity; management also described the pickup in November as preliminary.

Endeavour Silver Corp.

EXK Q3 2026

Endeavour Silver fell 2.6% after earnings. The quarter’s higher production and cash flow came alongside a cut to 2026 production guidance, with Guanaceví’s below-plan silver grades and operational disruptions weighing on the outlook.

Fold Holdings Inc

FLD Q3 2026

Fold shares fell 8.5% after earnings, with the transcript pointing to a soft retail Bitcoin market as the clearest near-term headwind. Management highlighted new balance products and higher custody and trading revenue, but emphasized a strategic shift toward gathering deposits and acknowledged that credit-card growth remains constrained without a credit facility.

Firefly Aerospace, Inc.

FLY Q3 2026

Firefly’s shares rose 12.3% after earnings. The call’s clearest positive was a nondilutive, more-than-$1.3 billion AST SpaceMobile agreement, though revenue is expected to ramp gradually, with engine deliveries beginning in year two and significant investment required.

Freehold Royalties Ltd.

FRHLF Q3 2026

Freehold’s shares rose 5.0% after earnings, with investors responding to unchanged quarter-over-quarter revenue of CAD 100 million despite lower benchmark WTI prices and rising drilling activity. The main growth opportunity is still ahead: increased U.S. activity is expected to flow into production in 2027, while the new Duvernay investment is tied to development milestones.

two

GILT Q3 2026

Gilat’s shares fell 20.6% after earnings, with the key disappointment likely its lower revenue outlook as commercial customer orders and deployments shift into 2027 and beyond. Management reduced full-year revenue guidance to $455 million–$475 million, despite maintaining a narrower adjusted EBITDA outlook.

Hannover Ruck SE

HNR1.DE Q3 2026

Hannover Re’s first-nine-month results were solid but the share reaction was muted, up 1.0%. Strong profitability and investment returns were tempered by intensified P&C competition, currency-affected reported growth and a lower-than-average Q3 contribution to solvency.

Infineon Technologies AG

IFNNY Q4 2026

Infineon’s shares rose 3.6% after the company forecast fiscal 2027 revenue of around €20 billion and a segment margin in the mid-20s, following 12% revenue growth and improving profitability in fiscal 2026. The outlook points to growth accelerating, though it also comes with planned fab investment of €3–3.5 billion.

Medios AG

ILM1.DE Q3 2026

Medios fell 0.4% after the earnings update, a roughly flat reaction to nine-month revenue growth of 6.7% and confirmed 2026 guidance. The picture is mixed: pricing pressure and higher international material costs weighed on profitability, with EBITDA pre margin down to 4.1% from 4.6% a year earlier.

Gladstone Land Corporation

LAND Q3 2026

Gladstone Land’s shares rose 7.0% after earnings, with investors seemingly responding to stronger-than-expected 2025 almond and pistachio harvests and sharply higher expected pistachio pricing. The outlook remains uncertain: lower 2026 crop yields may weigh on 2027 earnings, and management expects a smaller earnings pattern next year.

Lithium Argentina AG

LAR Q3 2026

Lithium Argentina shares fell 11.3% after earnings, despite higher quarterly revenue and EBITDA. The transcript points to cautious near-term lithium-market sentiment and a growth plan still dependent on permits, approvals and project economics; it does not identify a specific quarterly operating miss.

Liquidia Corporation

LQDA Q3 2026

Liquidia’s shares rose 7.4% after earnings, as investors appeared to reward 31% third-quarter net product sales growth and signs that YUTREPIA shipments reached a launch high in October despite litigation-related uncertainty. The outlook remains dependent on referrals recovering from October’s pause; management described October as a floor, but that recovery has yet to be demonstrated.

Mercury Systems, Inc.

MRCY Q1 2027

Mercury’s shares rose 5.7% after the company reported record Q1 bookings and revenue and raised its FY27 outlook. The transcript also points to improving production execution and defense-program demand, though free cash flow remained negative.

McEwen Mining Inc.

MUX Q3 2026

The stock fell 21.6% after a quarter management called “very unacceptable,” with operating shortfalls, lower production and elevated costs across Gold Bar, Fox and San Jose weighing on results. Management cited site-specific problems and pointed to October improvements, but those were not enough to offset the disappointing quarter.

Recent Dates

Browse by Company (3611)

AFL
Aflac Incorporated
4
AFRM
Affirm Holdings, Inc.
3
AG
First Majestic Silver Corp.
2
AG.TO
First Majestic Silver Corp.
2
AGI
Alamos Gold Inc.
4
AGI.AX
Ainsworth Game Technology Limited
1
AGI.TO
Alamos Gold Inc.
2
AGL
agilon health, inc.
1
AGL.AX
AGL Energy Limited
2
AGM
Federal Agricultural Mortgage Corporation
1
AGN.AS
Aegon N.V.
1
AGNC
AGNC Investment Corp.
3
AGO
Assured Guaranty Ltd.
1
AGRO
Adecoagro S.A.
1
AGS.BR
ageas SA/NV
1
AGX
Argan, Inc.
1
AGYS
Agilysys, Inc.
2
AHCO
AdaptHealth Corp.
1
AHH
Armada Hoffler Properties, Inc.
1
AHR
American Healthcare REIT, Inc.
4
AI
C3.ai, Inc.
2
AI.PA
L'Air Liquide S.A.
2
AIA.AT
ATHENS INTERNATIONAL AIRPORT S.
1
AIG
American International Group, Inc.
4
AIN
Albany International Corp.
1
AIR
AAR Corp.
2
AIR.PA
Airbus SE
3
AIRI
Air Industries Group
1
AIT
Applied Industrial Technologies, Inc.
2
AIZ
Assurant, Inc.
2
AJG
Arthur J. Gallagher & Co.
3
AKA
a.k.a. Brands Holding Corp.
2
AKAM
Akamai Technologies, Inc.
2
AKBA
Akebia Therapeutics, Inc.
2
AKBLF
ALK-Abello A/S
1
AKER.OL
Aker ASA
1
AKZA.AS
Akzo Nobel N.V.
1
ALA.TO
AltaGas Ltd.
3
ALAB
Astera Labs, Inc. Common Stock
2
AL
ALAR
Alarum Technologies Ltd. American Depositary Share
2
ALB
Albemarle Corporation
5
ALC
Alcon Inc.
2
ALD.AX
Ampol Limited
1
ALFEN.AS
Alfen N.V.
2
ALGM
Allegro MicroSystems, Inc.
2
ALGN
Align Technology, Inc.
5
ALGT
Allegiant Travel Company
3
ALHC
Alignment Healthcare, Inc.
1
ALIT
Alight, Inc.
3
ALIZY
Allianz SE
1
ALK
Alaska Air Group, Inc.
2
ALK-B.CO
ALK-Abelló A/S
1
ALK.TO
Alkane Resources Ltd.
1
ALKS
Alkermes plc
3
ALL
The Allstate Corporation
4
ALL-PB
The Allstate Corporation
1
ALLE
Allegion plc
3
ALLO
Allogene Therapeutics, Inc.
1
ALLT
Allot Ltd.
2
ALLY
Ally Financial Inc.
3

Track Earnings for Your Portfolio

Get personalized earnings recaps delivered to your inbox for the stocks you own.

Sign Up Free